HDAC inhibition increases Ewing sarcoma sensitivity to chemotherapy

被引:0
|
作者
Smith, Kaitlyn H.
Sholler, Chloe
Gandra, Divya
McKinney, Kimberly
Dykema, Karl
Nagulapally, Abhinav
Trovillion, Erin
机构
关键词
D O I
10.1158/1538-7445.AM2023-6252
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
6252
引用
收藏
页数:2
相关论文
共 50 条
  • [41] USE OF MR IMAGING TO ASSESS RESULTS OF CHEMOTHERAPY FOR EWING SARCOMA
    LEMMI, MA
    FLETCHER, BD
    MARINA, NM
    SLADE, W
    PARHAM, DM
    JENKINS, JJ
    MEYER, WH
    AMERICAN JOURNAL OF ROENTGENOLOGY, 1990, 155 (02) : 343 - 346
  • [42] Chemotherapy for Spinal Cord Compression due to Ewing Sarcoma in a Girl
    Nagahama, Jun
    Kodama, Yuichi
    Abematsu, Takanari
    Nakagawa, Shunsuke
    Nishikawa, Takurou
    Tanabe, Takayuki
    Shinkoda, Yuichi
    Okamoto, Yasuhiro
    Kawano, Yoshifumi
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S101 - S101
  • [43] Myeloablative chemotherapy with autologous stem cell rescue for Ewing sarcoma
    A L Gilman
    J Oesterheld
    Bone Marrow Transplantation, 2008, 42 : 761 - 761
  • [44] Monophasic Synovial Sarcoma in the Elbow Misclassified but Successfully Treated as Ewing's Sarcoma with Chemotherapy
    Madariaga, Maria Cecilia
    Duke, Alexander
    Hoda, Syed T.
    Khan, Fazel
    ORTHOPEDIC RESEARCH AND REVIEWS, 2021, 13 : 241 - 245
  • [45] Correction to: Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis
    Oxana Schmidt
    Nadja Nehls
    Carolin Prexler
    Kristina von Heyking
    Tanja Groll
    Katharina Pardon
    Heathcliff D. Garcia
    Tim Hensel
    Dennis Gürgen
    Anton G. Henssen
    Angelika Eggert
    Katja Steiger
    Stefan Burdach
    Günther H. S. Richter
    Journal of Experimental & Clinical Cancer Research, 41
  • [46] The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin
    Luis Ordonez, Jose
    Teresa Amaral, Ana
    Carcaboso, Angel M.
    Herrero-Martin, David
    del Carmen Garcia-Macias, Maria
    Sevillano, Vicky
    Alonso, Diego
    Pascual-Pasto, Guillem
    San-Segundo, Laura
    Vila-Ubach, Monica
    Rodrigues, Telmo
    Fraile, Susana
    Teodosio, Cristina
    Mayo-Iscar, Agustin
    Aracil, Miguel
    Maria Galmarini, Carlos
    Tirado, Oscar M.
    Mora, Jaume
    de Alava, Enrique
    ONCOTARGET, 2015, 6 (22) : 18875 - 18890
  • [47] Sensitivity of Ewing's sarcoma to TRAIL-induced apoptosis
    Kontny, HU
    Hämmerle, K
    Klein, R
    Shayan, P
    Mackall, CL
    Niemeyer, CM
    CELL DEATH AND DIFFERENTIATION, 2001, 8 (05): : 506 - 514
  • [48] Sensitivity of Ewing's sarcoma to TRAIL-induced apoptosis
    H U Kontny
    K Hämmerle
    R Klein
    P Shayan
    C L Mackall
    C M Niemeyer
    Cell Death & Differentiation, 2001, 8 : 506 - 514
  • [49] Unraveling the Resistance of IGF-Pathway Inhibition in Ewing Sarcoma
    de Groot, Stefanie
    Rottgering, Bas
    Gelderblom, Hans
    Pijl, Hanno
    Szuhai, Karoly
    Kroep, Judith R.
    CANCERS, 2020, 12 (12) : 1 - 18
  • [50] Emergence of persister cells following bromodomain inhibition in Ewing sarcoma
    Ganapathi, Shireen S.
    Garcia, Nicolas M.
    Sirihorachai, Veerin R.
    Lawlor, Elizabeth R.
    CLINICAL CANCER RESEARCH, 2022, 28 (18)